Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Chubb
US Army
US Department of Justice
Queensland Health
Boehringer Ingelheim
Cantor Fitzgerald
QuintilesIMS

Generated: May 28, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,476,669

« Back to Dashboard

Summary for Patent: 5,476,669
Title: Method for treatment of gastro intestinal disorders
Abstract:A method is disclosed for preventing the recurrence of duodenal ulcer associated with Campylobacter pylori (Helicobacter pylori) infection in a patient suffering from duodenal ulcer disease associated with Campylobacter pylori infection by administering a pharmaceutically acceptable bismuth compound, a first antibiotic selected from the group consisting of tetracycline and penicillins, and a second antibiotic which is metronidazole.
Inventor(s): Borody; Thomas J. (Five Dock, AU)
Assignee: Examed Australia Pty. Ltd. (New South Wales, AU) Ostapat Pty. Limited (New South Wales, AU) Gastro Services Pty. Limited (New South Wales, AU) Capability Services Pty. Limited (New South Wales, AU)
Application Number:07/937,421
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,476,669

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,476,669

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPI4838Oct 12, 1987
AustraliaPI5985Dec 18, 1987
AustraliaPI7513Mar 30, 1988

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Argus Health
Citi
Mallinckrodt
Merck
Deloitte
Federal Trade Commission
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.